http://www.ndfresearch.com/blog

Stuart Roberts

Want a sure-fire way to make money in biotech and medical device stocks? There is none. There are, however, certain things you can do to maximise your chances of success. I have been arguing lately that one of the better ways to do that is by buying stock in companies... Show More

Stuart Roberts

Are you bullish on New Zealand at the moment? If you are, you ought to check out what's going on in the country's emerging Life Sciences scene. This is the country that created Fisher & Paykel Healthcare as well as the A2 Milk Company, and, as Xero has shown us,... Show More

Stuart Roberts

Sirtex (ASX: SRX), whose SIR-Spheres product treats liver cancer through localised radiotherapy, had a good FY16, with revenue of A$232m (up 32%) and EBITDA of $70m (up 40%). In constant currency terms revenue rose 17%, in line with dose unit growth, but that was in line with the experience of... Show More

Stuart Roberts

Everyone agrees that mental illness is something we need to do more about. So it's heartening to know that the Australian Life Sciences industry is potentially able to do something about it. A couple of years ago I wrote about a diagnostic tool being developed by a Sydney-based company now... Show More